mevalonic acid has been researched along with Myeloproliferative Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hasselbalch, HC; Riley, CH | 2 |
2 review(s) available for mevalonic acid and Myeloproliferative Disorders
| Article | Year |
|---|---|
Statins in the treatment of polycythaemia vera and allied disorders: an antithrombotic and cytoreductive potential?
Topics: Angiogenesis Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Cell Division; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mevalonic Acid; Myeloproliferative Disorders; Polycythemia Vera; Thrombocythemia, Essential | 2006 |
The mevalonate pathway as a therapeutic target in the Ph-negative chronic myeloproliferative disorders.
Topics: Antigens, CD34; Chronic Disease; Humans; Mevalonic Acid; Myeloproliferative Disorders; Philadelphia Chromosome | 2007 |